发明名称 |
Method of inhibiting regulatory T-cell activity by administering an antibody that inhibits interleukin 35 |
摘要 |
Methods for regulating T cell function in a subject, particularly regulatory T cell activity are provided. Methods of the invention include administering to a subject a therapeutically effective amount of an Interleukin 35-specific binding agent, such as an antibody or small molecule inhibitor. The invention further provides methods for enhancing the immunogenicity of a vaccine or overcoming a suppressed immune response to a vaccine in a subject, including administering to the subject a therapeutically effective amount of an IL35-specific binding agent and administering to the subject a vaccine. In one embodiment the vaccine is a cancer vaccine. |
申请公布号 |
US8784807(B2) |
申请公布日期 |
2014.07.22 |
申请号 |
US200712441166 |
申请日期 |
2007.09.24 |
申请人 |
St. Jude Children's Research Hospital |
发明人 |
Vignali Dario;Workman Creg;Collison Lauren;Vignali Kate |
分类号 |
A61K39/395 |
主分类号 |
A61K39/395 |
代理机构 |
Alston & Bird LLP |
代理人 |
Alston & Bird LLP |
主权项 |
1. A method of inhibiting a regulatory T-cell function in a subject, comprising administering to a subject in need of inhibiting a regulatory T-cell function a therapeutically effective amount of a specific binding agent, wherein said specific binding agent comprises an antibody that inhibits Interleukin 35 (IL35) activity, wherein the therapeutically effective amount of said antibody inhibits a regulatory T-cell function in said subject. |
地址 |
Memphis TN US |